Imbria Pharmaceuticals


Imbria Pharmaceuticals’ mission is to translate our understanding of cellular metabolism into innovative medicines that improve the lives of patients with limited or inadequate treatment options.

Industries

Employees

11-50

Links


Org chart

Komal Joshi
Chief Financial Officer
Arash Yavari
Chief Scientific Officer
Karen Jauregui
Senior Vice President, Regulatory Affairs, Quality, And CMC
Paul Chamberlin
SVP, Clinical Development

Board & advisors

Andrew Levin
Chairman
John Young
Director
Nikola Trbovic
Board Observer


Offices